Galapagos announces appointment of new CFO and Board Member

05-Jun-2009 - Belgium

Galapagos NV announced that its Annual General Shareholders' meeting held on 2 June 2009 approved Dr. Werner Cautreels' appointment to the Board of Directors. Galapagos also announced the appointment of Guillaume Jetten as Chief Financial Officer, effective 1 July 2009. Mr. Jetten succeeds Leo Steenbergen, who will continue to serve as Galapagos' CFO until July and will assist in the transition process. Furthermore, Galapagos stated that the Extraordinary General Shareholders' Meeting (EGM) held on 2 June 2009 approved the offer of 135,100 warrants for the benefit of directors and new CFO of the Company.

Leo Steenbergen joined Galapagos as CFO in June 2007, with the mission to restructure the finance operations to support sustainability and further growth of the business. As Galapagos has achieved a profitable turnaround of the service division and completed its reorganization and consolidation activities, he has accomplished this mission and will be leaving the Company to pursue other projects.

Before joining Galapagos, Guillaume Jetten (41) was Executive Board Member and CFO of SDU Holding BV, a privately owned company specialized in publishing and identification documents, where he played a key role in the Company's transition from a state owned firm since joining in 2007. Previously, he was CFO of Wolters Kluwer Health in Chicago, where he drove initiatives to improve global financial and operating processes and create synergies of scale. He also served as Vice President Group Accounting at Wolters Kluwer NV and held positions with increasing level of responsibilities at Merck, Sharpe & Dohme BV. Mr. Jetten holds a masters degree in economics from the University of Maastricht and is a Certified Registered Accountant.

Galapagos also announced that its Annual General Shareholders' Meeting held on 2 June 2009 approved the appointment of Dr. Werner Cautreels as a new Independent Director on the Board of Directors for a period until the 2010 Annual Shareholders' meeting. Laurent Ganem, MD and Geoff McMillan will no longer serve on Galapagos' Board of Directors.

Werner Cautreels (56) is Global CEO of Solvay Pharmaceuticals, headquartered in Brussels, Belgium. He joined Solvay Pharmaceuticals in 1998 as Global Head of Research and Development and was appointed CEO in January 2005. Prior to joining Solvay he was employed by Sanofi, Sterling Winthrop and Nycomed-Amersham in a variety of R&D management positions in Europe and in the United States. Dr. Cautreels holds a doctorate in organic chemistry from the University of Antwerp, Belgium.

https://www.bionity.com/en/news/101628/galapagos-announces-appointment-of-new-cfo-and-board-member.html